{"id":"https://openalex.org/W1992964537","doi":"https://doi.org/10.1056/nejm199211053271902","title":"Interferon Alfa Combined with Cytotoxic Chemotherapy for Patients with Non-Hodgkin's Lymphoma","display_name":"Interferon Alfa Combined with Cytotoxic Chemotherapy for Patients with Non-Hodgkin's Lymphoma","publication_year":1992,"publication_date":"1992-11-05","ids":{"openalex":"https://openalex.org/W1992964537","doi":"https://doi.org/10.1056/nejm199211053271902","mag":"1992964537","pmid":"https://pubmed.ncbi.nlm.nih.gov/1406835"},"language":"en","primary_location":{"id":"doi:10.1056/nejm199211053271902","doi":"https://doi.org/10.1056/nejm199211053271902","is_oa":false,"landing_page_url":"https://doi.org/10.1056/nejm199211053271902","pdf_url":null,"source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109006414","display_name":"Richard V. Smalley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I135310074","display_name":"University of Wisconsin\u2013Madison","ror":"https://ror.org/01y2jtd41","country_code":"US","type":"education","lineage":["https://openalex.org/I135310074"]},{"id":"https://openalex.org/I4210103341","display_name":"University of Wisconsin Carbone Cancer Center","ror":"https://ror.org/01e4byj08","country_code":"US","type":"funder","lineage":["https://openalex.org/I135310074","https://openalex.org/I2799905417","https://openalex.org/I4210103341","https://openalex.org/I4210132596"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard V. Smalley","raw_affiliation_strings":["University of Wisconsin Clinical Cancer Center, Madison","Synertron, Inc., Madison, Wis., . Address reprint requests to Dr. Smalley at Synertron, Inc., 575 Science Dr., Madison, WI 53711","University of Wisconsin Clinical Cancer Center, Madison, . Address reprint requests to Dr. Smalley at Synertron, Inc., 575 Science Dr., Madison, WI 53711"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Wisconsin Clinical Cancer Center, Madison","institution_ids":["https://openalex.org/I135310074","https://openalex.org/I4210103341"]},{"raw_affiliation_string":"Synertron, Inc., Madison, Wis., . Address reprint requests to Dr. Smalley at Synertron, Inc., 575 Science Dr., Madison, WI 53711","institution_ids":["https://openalex.org/I135310074"]},{"raw_affiliation_string":"University of Wisconsin Clinical Cancer Center, Madison, . Address reprint requests to Dr. Smalley at Synertron, Inc., 575 Science Dr., Madison, WI 53711","institution_ids":["https://openalex.org/I135310074","https://openalex.org/I4210103341"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108208658","display_name":"Janet W. Andersen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Janet W. Andersen","raw_affiliation_strings":["Biostatistical Center, Dana\u2013Farber Cancer Institute, Boston, . Address reprint requests to Dr. Smalley at Synertron, Inc., 575 Science Dr., Madison, WI 53711"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biostatistical Center, Dana\u2013Farber Cancer Institute, Boston, . Address reprint requests to Dr. Smalley at Synertron, Inc., 575 Science Dr., Madison, WI 53711","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103887854","display_name":"Michael Hawkins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael J. Hawkins","raw_affiliation_strings":["Georgetown University, Washington, D.C., . Address reprint requests to Dr. Smalley at Synertron, Inc., 575 Science Dr., Madison, WI 53711"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgetown University, Washington, D.C., . Address reprint requests to Dr. Smalley at Synertron, Inc., 575 Science Dr., Madison, WI 53711","institution_ids":["https://openalex.org/I184565670"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004420848","display_name":"Vandana Bhide","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I135310074","display_name":"University of Wisconsin\u2013Madison","ror":"https://ror.org/01y2jtd41","country_code":"US","type":"education","lineage":["https://openalex.org/I135310074"]},{"id":"https://openalex.org/I4210103341","display_name":"University of Wisconsin Carbone Cancer Center","ror":"https://ror.org/01e4byj08","country_code":"US","type":"funder","lineage":["https://openalex.org/I135310074","https://openalex.org/I2799905417","https://openalex.org/I4210103341","https://openalex.org/I4210132596"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vandana Bhide","raw_affiliation_strings":["Synertron, Inc., Madison, Wis., . Address reprint requests to Dr. Smalley at Synertron, Inc., 575 Science Dr., Madison, WI 53711","University of Wisconsin Clinical Cancer Center, Madison, . Address reprint requests to Dr. Smalley at Synertron, Inc., 575 Science Dr., Madison, WI 53711"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Synertron, Inc., Madison, Wis., . Address reprint requests to Dr. Smalley at Synertron, Inc., 575 Science Dr., Madison, WI 53711","institution_ids":["https://openalex.org/I135310074"]},{"raw_affiliation_string":"University of Wisconsin Clinical Cancer Center, Madison, . Address reprint requests to Dr. Smalley at Synertron, Inc., 575 Science Dr., Madison, WI 53711","institution_ids":["https://openalex.org/I135310074","https://openalex.org/I4210103341"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062302578","display_name":"Michael J. O\u2019Connell","orcid":"https://orcid.org/0000-0003-3777-8556","observed_orcids":["https://orcid.org/0000-0003-3777-8556"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael J. O'Connell","raw_affiliation_strings":["Mayo Clinic, Rochester, Minn., . Address reprint requests to Dr. Smalley at Synertron, Inc., 575 Science Dr., Madison, WI 53711"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, Minn., . Address reprint requests to Dr. Smalley at Synertron, Inc., 575 Science Dr., Madison, WI 53711","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109268161","display_name":"Martin M. Oken","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martin M. Oken","raw_affiliation_strings":["Virginia Piper Cancer Institute, Minneapolis, . Address reprint requests to Dr. Smalley at Synertron, Inc., 575 Science Dr., Madison, WI 53711"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virginia Piper Cancer Institute, Minneapolis, . Address reprint requests to Dr. Smalley at Synertron, Inc., 575 Science Dr., Madison, WI 53711","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112252438","display_name":"Ernest C. Borden","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204308271","display_name":"Medical College of Wisconsin","ror":"https://ror.org/00qqv6244","country_code":"US","type":"education","lineage":["https://openalex.org/I204308271"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ernest C. Borden","raw_affiliation_strings":["Medical College of Wisconsin, Milwaukee, . Address reprint requests to Dr. Smalley at Synertron, Inc., 575 Science Dr., Madison, WI 53711"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical College of Wisconsin, Milwaukee, . Address reprint requests to Dr. Smalley at Synertron, Inc., 575 Science Dr., Madison, WI 53711","institution_ids":["https://openalex.org/I204308271"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":18.3893,"has_fulltext":false,"cited_by_count":170,"citation_normalized_percentile":{"value":0.99494311,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"327","issue":"19","first_page":"1336","last_page":"1341"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interferon-alpha","display_name":"interferon-alpha","score":0.996999979019165},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.9940000176429749},{"id":"https://openalex.org/keywords/indolent-lymphoma","display_name":"indolent lymphoma","score":0.8029999732971191},{"id":"https://openalex.org/keywords/intermediate-grade-lymphoma","display_name":"intermediate-grade lymphoma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/conventional-chemotherapy","display_name":"cytotoxic chemotherapy","score":0.6449999809265137},{"id":"https://openalex.org/keywords/chop-chemotherapy","display_name":"CHOP chemotherapy","score":0.7929999828338623},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.8930000066757202},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.8209999799728394},{"id":"https://openalex.org/keywords/vincristine","display_name":"vincristine","score":0.9919999837875366},{"id":"https://openalex.org/keywords/prednisone","display_name":"prednisone","score":0.9980000257492065},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.5730000138282776},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.6830000281333923},{"id":"https://openalex.org/keywords/time-to-treatment-failure","display_name":"time to treatment failure","score":0.8790000081062317}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9126781225204468},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.7161613702774048},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.6679485440254211},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6646557450294495},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6258845925331116},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.6200131177902222},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.6078693866729736},{"id":"https://openalex.org/C2781228144","wikidata":"https://www.wikidata.org/wiki/Q6046441","display_name":"Interferon alfa","level":4,"score":0.6032691597938538},{"id":"https://openalex.org/C2909179924","wikidata":"https://www.wikidata.org/wiki/Q6046488","display_name":"Alpha interferon","level":3,"score":0.5829557180404663},{"id":"https://openalex.org/C2781214270","wikidata":"https://www.wikidata.org/wiki/Q4692282","display_name":"Aggressive lymphoma","level":4,"score":0.5409179329872131},{"id":"https://openalex.org/C2778720950","wikidata":"https://www.wikidata.org/wiki/Q424972","display_name":"Prednisone","level":2,"score":0.5261109471321106},{"id":"https://openalex.org/C2778476748","wikidata":"https://www.wikidata.org/wiki/Q1138590","display_name":"Non-Hodgkin's lymphoma","level":3,"score":0.5160150527954102},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4917607605457306},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.44532153010368347},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.41359952092170715},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.32915961742401123},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.30719560384750366},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3008861839771271},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.08986860513687134}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011241","descriptor_name":"Prednisone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1056/nejm199211053271902","doi":"https://doi.org/10.1056/nejm199211053271902","is_oa":false,"landing_page_url":"https://doi.org/10.1056/nejm199211053271902","pdf_url":null,"source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},{"id":"pmid:1406835","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1406835","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The New England journal of medicine","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G1848774630","display_name":"EASTERN COOPERATIVE ONCOLOGY GROUP","funder_award_id":"U10CA006594","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G2087378654","display_name":"EASTERN COOPERATIVE ONCOLOGY GROUP","funder_award_id":"U10CA014958","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5066121848","display_name":"Eastern Cooperative Oncology Group Studies","funder_award_id":"U10CA014548","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W994251281","https://openalex.org/W1595896331","https://openalex.org/W1874821077","https://openalex.org/W1966946838","https://openalex.org/W1987797112","https://openalex.org/W1988493767","https://openalex.org/W1995578078","https://openalex.org/W1995628336","https://openalex.org/W1996549520","https://openalex.org/W2001783515","https://openalex.org/W2005027156","https://openalex.org/W2022379487","https://openalex.org/W2024286235","https://openalex.org/W2034578998","https://openalex.org/W2035469650","https://openalex.org/W2037650318","https://openalex.org/W2049301091","https://openalex.org/W2065271139","https://openalex.org/W2072163745","https://openalex.org/W2074673068","https://openalex.org/W2076668534","https://openalex.org/W2079668255","https://openalex.org/W2080557994","https://openalex.org/W2088455335","https://openalex.org/W2093767787","https://openalex.org/W2136883754","https://openalex.org/W2144360148","https://openalex.org/W2154289475","https://openalex.org/W2171796002","https://openalex.org/W2175875757","https://openalex.org/W2179208207","https://openalex.org/W2188971903","https://openalex.org/W2190576586","https://openalex.org/W2269595883","https://openalex.org/W2339387502","https://openalex.org/W2339932366","https://openalex.org/W2344245690","https://openalex.org/W2396514826","https://openalex.org/W2412662667","https://openalex.org/W4234165429"],"related_works":["https://openalex.org/W2328311363","https://openalex.org/W2093312029","https://openalex.org/W2055208820","https://openalex.org/W2417978416","https://openalex.org/W2056847748","https://openalex.org/W2253479946","https://openalex.org/W2078556957","https://openalex.org/W2268917628","https://openalex.org/W2034578998","https://openalex.org/W2472330091"],"abstract_inverted_index":{"BACKGROUND:":[0],"Interferon":[1,148,170],"alfa":[2,52,149],"has":[3,35],"been":[4,36],"found":[5],"to":[6,53,83,93,109,133,174],"be":[7],"effective":[8,182],"as":[9],"an":[10,181],"antitumor":[11,183],"agent":[12,184],"(with":[13],"a":[14,41,84,126,152,175],"response":[15,144],"rate":[16],"of":[17,49,68,86,142],"30":[18],"percent)":[19],"in":[20,29,56,129,185],"patients":[21,57,79,186],"with":[22,31,58,97,187],"low-grade":[23,61,190],"non-Hodgkin's":[24,33,62,70,193],"lymphoma,":[25,71],"but":[26,120],"its":[27],"effectiveness":[28,48],"those":[30],"intermediate-grade":[32,69,192],"lymphoma":[34,63],"less":[37],"adequately":[38],"tested.":[39],"In":[40],"prospective":[42],"randomized":[43],"study":[44],"we":[45],"evaluated":[46],"the":[47,121,131,140,162],"adding":[50],"interferon":[51,99,124],"cytotoxic":[54],"chemotherapy":[55,178],"clinically":[59,188],"aggressive,":[60],"and":[64,90,139],"certain":[65],"histologic":[66],"variants":[67],"not":[72],"including":[73,123],"diffuse":[74],"histiocytic":[75],"lymphoma.":[76,194],"METHODS:":[77],"The":[78,113],"were":[80,164],"randomly":[81],"assigned":[82],"regimen":[85,95,122],"cyclophosphamide,":[87],"vincristine,":[88],"prednisone,":[89],"doxorubicin":[91],"or":[92,191],"this":[94],"combined":[96],"recombinant":[98],"alfa.":[100],"Treatment":[101],"was":[102],"administered":[103],"every":[104],"four":[105],"weeks,":[106],"for":[107,166],"8":[108],"10":[110],"cycles.":[111],"RESULTS:":[112],"two":[114],"regimens":[115],"produced":[116],"comparable":[117],"objective":[118],"responses,":[119],"had":[125,151],"greater":[127,153],"effect":[128,154],"prolonging":[130],"time":[132],"treatment":[134],"failure":[135],"(P":[136,145,158],"<":[137],"0.001)":[138],"duration":[141],"complete":[143],"=":[146,159],"0.03).":[147],"also":[150],"on":[155],"overall":[156],"survival":[157],"0.014)":[160],"when":[161,172],"results":[163],"adjusted":[165],"important":[167],"covariates.":[168],"CONCLUSIONS:":[169],"alfa,":[171],"added":[173],"four-drug":[176],"doxorubicin-based":[177],"regimen,":[179],"is":[180],"aggressive":[189]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}